CX3CL1 and atherosclerosis: Solid literature evidence supports the contribution of specific monocyte subsets to the process of atherosclerosis [34,35], with studies in mice demonstrating the recruitment of non-classical monocytes into the plaque via the chemokine receptor CX3CR1 and its ligand CX3CL1/FKN [97].